Market News
Critical Stocks at Risk without a Bond Rally
Stock Vulnerability Exposes Underwhelming Performance Threat
Photo by Yuichiro Chino/Moment via Getty Images Piper Sandler has flagged 31 stocks from the Russell 1000 (NYSEARCA:IWF) universe susceptible to underperformance, should interest ...
Last Month’s U.S. Crypto Crime Recap
A Recap of Last Month’s U.S. Crypto Crime Log
While our attention was focused on exchange-traded funds earlier this month, federal regulators in the U.S. announced charges or sentences for various crypto parties. ...
Amplify Your Voice: Navigating the 2024 Election with VoterVoice from FiscalNote (NYSE: NOTE)
Amplify Your Voice: Navigating the 2024 Election with VoterVoice from FiscalNote (NYSE: NOTE)
As the 2024 presidential election approaches, the U.S. stands at a pivotal crossroads, with the state of its politics seemingly more complex than ever ...
GE HealthCare Technologies Shines Amidst Rising Stocks
GE HealthCare Technologies Shines Amidst Rising Stocks
February 6, 2024 10:20 AM | 2 min read U.S. stocks traded mostly higher, with the Dow Jones gaining around 70 points on Tuesday. ...
Equipment Incident: Diamond Offshore Drilling Shares Plummet
Equipment Incident: Diamond Offshore Drilling Shares Plummet
Sharkyjones/iStock Editorial via Getty Images Diamond Offshore Drilling (NYSE:DO) shares fell by 2.1% in early trading on Tuesday following an equipment mishap on a ...
Top Performers and Surprises: Stocks to Keep An Eye on This Tuesday
jetcityimage/iStock Editorial via Getty Images U.S. stock index futures on Tuesday pointed to a slightly higher open, as market participants geared up for a ...
Thinking Big With Nuvve’s Vehicle-To-Grid Solution
Unlocking Opportunities with Nuvve’s Vehicle-to-Grid Technology
The vehicle-to-grid (V2G) market is in its infancy and could potentially be poised for growth as the number of electric vehicles on the road ...
Immunome’s Acquisition of AL102: A Boost for Desmoid Tumor Treatment
Immunome’s Acquisition of AL102: A Boost for Desmoid Tumor Treatment
Yuichiro Chino/Moment via Getty Images Immunome (NASDAQ:IMNM) Tuesday announced that it entered into a definitive asset purchase agreement with Ayala Pharmaceuticals (OTCQX:ADXS), a clinical-stage ...
Energizer Holdings Faces Revenue Decline Amid Weaker Battery Demand
Energizer Holdings Faces Revenue Decline Amid Weaker Battery Demand
Roberto/iStock via Getty Images Energizer Holdings (NYSE:ENR) reported a 6.3% year-over-year drop in sales for FQ1, amounting to $717M in revenue. During the quarter, ...













